Original language | English (US) |
---|---|
Pages (from-to) | S307 |
Journal | Annals of Oncology |
Volume | 33 |
DOIs | |
State | Published - 2022 |
P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022
M. Abdelrahim, A. Esmail, A. Saharia, S. Kodali, D. Victor, K. Heyne, R. Ghobrial
- Academic Institute
- Research Institute
- Department of Medicine
- Dr. Mary and Ron Neal Cancer Center
- Lynda K. and David M. Underwood Center for Digestive Disorders
- Houston Methodist Hospital
- Houston Methodist
- Weill Cornell Medical College
- Department of Surgery
- Sherrie and Alan Conover Center for Liver Disease & Transplantation
- J.C. Walter Jr. Transplant Center
- Immunobiology & Transplant Science Center
Research output: Contribution to journal › Article › peer-review